|
MRPS23 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62647673107585E-12 |
| Normal-vs-Stage2 |
8.16970000000472E-05 |
| Normal-vs-Stage3 |
1.98406999999401E-05 |
| Normal-vs-Stage4 |
8.11190000000739E-05 |
| Stage1-vs-Stage2 |
7.026200E-01 |
| Stage1-vs-Stage3 |
2.604800E-01 |
| Stage1-vs-Stage4 |
1.678500E-02 |
| Stage2-vs-Stage3 |
6.326800E-01 |
| Stage2-vs-Stage4 |
5.909900E-02 |
| Stage3-vs-Stage4 |
2.029600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.85670367969237E-11 |
| Normal-vs-Asian |
1.173830E-01 |
| Caucasian-vs-AfricanAmerican |
3.871800E-01 |
| Caucasian-vs-Asian |
7.492200E-01 |
| AfricanAmerican-vs-Asian |
9.277800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
3.48943096639687E-12 |
| Male-vs-Female |
8.173200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.56969999998147E-07 |
| Normal-vs-Extreme_Weight |
1.59340318717227E-11 |
| Normal-vs-Obese |
2.16019979681903E-10 |
| Normal-vs-Extreme_Obese |
1.536490E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.923000E-01 |
| Normal_Weight-vs-Obese |
7.100000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.811200E-01 |
| Extreme_Weight-vs-Obese |
6.824200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.790400E-01 |
| Obese-vs-Extreme_Obese |
8.062600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.237300E-04 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
1.63691282750733E-12 |
| Normal-vs-Age(81-100Yrs) |
9.576300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.091000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.425810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.352600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.164000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.791800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.138600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
9.33642052558525E-12 |
| Normal-VS-KIRP CIMP |
2.176400E-02 |
| Normal-VS-Unclassified PRCC |
1.78288000000082E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.238400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.169000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.740200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.659400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.447190E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.839600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.86970000037867E-07 |
| Normal-vs-N1 |
4.34670000000192E-05 |
| Normal-vs-N2 |
1.138790E-01 |
| N0-vs-N1 |
4.810800E-01 |
| N0-vs-N2 |
4.464000E-01 |
| N1-vs-N2 |
6.867000E-01 |
|
|
